These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33962608)

  • 1. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
    MacDonald KW; Chanyi RM; Macklaim JM; Cadieux PA; Reid G; Burton JP
    BMC Oral Health; 2021 May; 21(1):245. PubMed ID: 33962608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
    Park JA; Lee GR; Lee JY; Jin BH
    Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
    Jansen PM; Abdelbary MMH; Conrads G
    PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
    Yoo HJ; Jwa SK; Kim DH; Ji YJ
    Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
    Karaçam S; Tunçer S
    Lett Appl Microbiol; 2023 Jan; 76(1):. PubMed ID: 36688767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coaggregation of Streptococcus salivarius with periodontopathogens: evidence for involvement of fimbriae in the interaction with Prevotella intermedia.
    Lévesque C; Lamothe J; Frenette M
    Oral Microbiol Immunol; 2003 Oct; 18(5):333-7. PubMed ID: 12930529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
    Laws GL; Hale JDF; Kemp RA
    Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1521-1529. PubMed ID: 34282568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro beneficial effects of Streptococcus dentisani as potential oral probiotic for periodontal diseases.
    Esteban-Fernández A; Ferrer MD; Zorraquín-Peña I; López-López A; Moreno-Arribas MV; Mira A
    J Periodontol; 2019 Nov; 90(11):1346-1355. PubMed ID: 31111495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells.
    Li Y; Guo H; Wang X; Lu Y; Yang C; Yang P
    Arch Oral Biol; 2015 Sep; 60(9):1387-93. PubMed ID: 26143497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Strain Probiotic Supplementation with a Product Containing Human-Native
    Cernioglo K; Kalanetra KM; Meier A; Lewis ZT; Underwood MA; Mills DA; Smilowitz JT
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959944
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial effect of probiotic bacteriocins on
    Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
    J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a bacteriocin-producing
    Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
    Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Begić G; Badovinac IJ; Karleuša L; Kralik K; Cvijanovic Peloza O; Kuiš D; Gobin I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
    Laws GA; Harold LK; Tagg JR; Hale JDF
    Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens.
    Chen YT; Hsieh PS; Ho HH; Hsieh SH; Kuo YW; Yang SF; Lin CW
    Lett Appl Microbiol; 2020 Apr; 70(4):310-317. PubMed ID: 31955445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
    Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
    Sarlin S; Tejesvi MV; Turunen J; Vänni P; Pokka T; Renko M; Tapiainen T
    Pediatr Infect Dis J; 2021 May; 40(5):394-402. PubMed ID: 33298762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis.
    Bostanci N; Allaker R; Johansson U; Rangarajan M; Curtis MA; Hughes FJ; McKay IJ
    Oral Microbiol Immunol; 2007 Feb; 22(1):52-60. PubMed ID: 17241171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety assessment of
    Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
    Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
    Chen TY; Hale JDF; Tagg JR; Jain R; Voss AL; Mills N; Best EJ; Stevenson DS; Bird PA; Walls T
    Probiotics Antimicrob Proteins; 2021 Jun; 13(3):734-738. PubMed ID: 33179212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.